Literature DB >> 25758554

Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.

Yoshihisa Shimada1, Hisashi Saji2, Keishi Otani3, Sachio Maehara3, Junichi Maeda3, Koichi Yoshida3, Yasufumi Kato3, Masaru Hagiwara3, Masatoshi Kakihana3, Naohiro Kajiwara3, Tatsuo Ohira3, Soichi Akata4, Norihiko Ikeda3.   

Abstract

OBJECTIVES: We reviewed the medical record of a series of patients with synchronous multiple lung cancers (SMLC), in an attempt to identify the optimal treatment strategy for multiple ground-glass opacities (GGOs).
MATERIALS AND METHODS: From 2004 to 2010, 1223 patients underwent complete resection of non-small cell lung cancer. Among these, there were 67 patients (5.5%) with SMLC with at least 1 of the nodules showing GGO appearance. SMLC was divided into the main cancer (MC) which was a main target based on its tumor size or radiological invasiveness and sub-nodules. According to consolidation/tumor ratio (CTR) on thin-section computed tomography, 67 cases were classified into GG-group (MC showing GGO-dominant lesion; CTR≤0.5) and GS-group (MC showing solid-dominant lesion; CTR>0.5).
RESULTS: There were 24 patients in the GG-group (36%) and 43 patients in the GS-group (64%). Surgical resections included 11 sublobar resections (SLs), 32 lobectomies, 19 lobectomy+SLs, and 4 bilobectomies. There were 39 patients with a total of 118 unresected GGOs after the initial surgery. Among them, the frequency of growth was 8% on a per-nodule basis with the median tumor doubling time of 1373 days, and new GGOs emerged in 15 patients (23%). Multivariate analysis demonstrated that larger size of MC and the GS-group was associated with poor prognosis, whereas growth of the residual GGOs, the development of new GGOs, or whether or not all GGOs were treated did not affect survival. The 5-year OS proportions were 95.8% for the GG-group and 68.0% for the GS-group (p=0.009), and 92.4% for a MC of ≤25 mm and 53.6% for a MC of >25 mm (p=0.008).
CONCLUSION: Survival of patients with multifocal GGOs is strongly affected by radiological findings of the MC. Strict surgical control for MC could be most important.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ground-glass opacity; Multiple lung cancer; Non-small cell lung cancer; Surgical resection

Mesh:

Year:  2015        PMID: 25758554     DOI: 10.1016/j.lungcan.2015.02.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  28 in total

1.  Separate or intrapulmonary metastasis?

Authors:  Yu-Chao Yu; Chien-Sheng Huang; Biing-Shiun Huang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Single-stage bilateral pulmonary resections by video-assisted thoracic surgery for multiple small nodules.

Authors:  Feng Yao; Haitang Yang; Heng Zhao
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

3.  Surgical treatment of synchronous multiple primary lung cancers: a retrospective analysis of 122 patients.

Authors:  Ming Liu; Wenxin He; Jie Yang; Gening Jiang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

4.  Surgical management of lung cancer with multiple lesions: implication of the new recommendations of the 8th edition of the TNM classification for lung cancer.

Authors:  David A Waller
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities.

Authors:  Stefano Bongiolatti; Roberto Corzani; Sara Borgianni; Fabiola Meniconi; Fabrizio Cipollini; Alessandro Gonfiotti; Domenico Viggiano; Piero Paladini; Luca Voltolini
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

6.  Epidermal growth factor receptor mutation accelerates radiographic progression in lung adenocarcinoma presented as a solitary ground-glass opacity.

Authors:  Qijue Lu; Ye Ma; Zhao An; Tiejun Zhao; Zhiyun Xu; Hezhong Chen
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

7.  Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.

Authors:  Ping-Chung Tsai; Chia Liu; Yi-Chen Yeh; Chun-Ku Chen; Po-Kuei Hsu; Hui-Shan Chen; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

8.  BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus.

Authors:  Fengxia Ding; Meisa Wang; Yibo Du; Shuangshuang Du; Zhongling Zhu; Zhao Yan
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 9.  New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies.

Authors:  Donglai Chen; Chenyang Dai; Xiermaimaiti Kadeer; Rui Mao; Yongbing Chen; Chang Chen
Journal:  Ther Clin Risk Manag       Date:  2018-01-31       Impact factor: 2.423

10.  Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers.

Authors:  Zhirong Zhang; Shugeng Gao; Yousheng Mao; Juwei Mu; Qi Xue; Xiaoli Feng; Jie He
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.